Abstract |
The aim of the present study was to evaluate the role of a weekly preoperative chemotherapy in locally advanced, unresectable gastric cancer. In all, 82 patients with an Eastern Oncology Cooperative Group PS <or=2 and normal cardiac function were enrolled onto the study. Surgical unresectability was confirmed in 52 patients (63%) at laparotomy, and in 30 (27%) cases by CT scan of the abdomen and endoscopic ultrasonography. Chemotherapy treatment was: cisplatin 40 mg x m(-2); 5-fluorouracil 500 mg x m(-2); epidoxorubicin 35 mg x m(-2); 6S-leucovorin 250 mg x m(-2) and glutathione 1.5 g x m(-2) (PELF). One cycle consisted of 8 weekly treatments. Response to chemotherapy was observed in 40 of 82 patients (49%): six (7%) complete and 34 (41%) partial responses, and in four (5%) cases a complete pathological response was confirmed. Of the 40 responding patients, 37 (45%) had potentially curative surgery. Grade 3/4 leucopenia and thrombocytopenia occurred in three and two patients. At a median follow-up of 48 months, 25 of the 37 resected patients (68%) were alive and 24 (65%) were disease free. The median and 4-year survival for the whole group was 17 months and 31%, respectively. The median survival was 12 months for inoperable patients and it was not reached in resected patients.
|
Authors | S Cascinu, M Scartozzi, R Labianca, V Catalano, R R Silva, S Barni, A Zaniboni, A D'Angelo, S Salvagni, G Martignoni, G D Beretta, F Graziano, R Berardi, V Franciosi, Italian Group for the Study of Digestive Tract Cancer (GISCAD) |
Journal | British journal of cancer
(Br J Cancer)
Vol. 90
Issue 8
Pg. 1521-5
(Apr 19 2004)
ISSN: 0007-0920 [Print] England |
PMID | 15083179
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Chemical References |
- Recombinant Proteins
- Granulocyte Colony-Stimulating Factor
- Epirubicin
- Levoleucovorin
- Glutathione
- Filgrastim
- Cisplatin
- Leucovorin
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects, therapeutic use)
- Cisplatin
(administration & dosage)
- Disease-Free Survival
- Drug Administration Schedule
- Epirubicin
(administration & dosage)
- Female
- Filgrastim
- Fluorouracil
(administration & dosage)
- Glutathione
(administration & dosage)
- Granulocyte Colony-Stimulating Factor
(administration & dosage)
- Humans
- Leucovorin
(administration & dosage)
- Leukopenia
(chemically induced)
- Levoleucovorin
- Male
- Middle Aged
- Neoadjuvant Therapy
- Recombinant Proteins
- Stomach Neoplasms
(drug therapy, pathology)
- Thrombocytopenia
(chemically induced)
- Treatment Outcome
|